Skip to main content
IONS
NASDAQ Life Sciences

Ionis Posts $243M in Third-Quarter Revenue

Tom Rudovsky · Reported by Dow Jones Newswires
More coverage: Biotech Stocks · Healthcare
Sentiment info
Positive
Importance info
7
Price
$37
Mkt Cap
$6.551B
52W Low
$38.305
52W High
$86.74
52W Position info
3.4% below low
Off High info
57% below high
Rel. Volume info
0.9× avg
Market data snapshot near publication time

IONS is trading near its 52-week low of $38.305 (3.4% below the low).

Summary

Ionis reported third-quarter revenue of $243M, up 55% from a year earlier. The quarter showed a loss of 66 cents per share and operating expenses of USD 373 Million. The company lowered its TRYNGOLZA 2026 sales guidance while reaffirming its 2026 total revenue, operating loss and cash guidance. The quarter lands after a heavy stretch of pipeline news: FDA approval of zilganersen in September, positive Phase 3 data for ulefnersen and sefaxersen, and the pelacarsen Phase 3 failure with Novartis. The stock sits near its 52-week low, so the revenue line and any commentary on TRYNGOLZA and DAWNZERA launch costs will carry weight.

At the time of this announcement, IONS was trading at $37.00 on NASDAQ in the Life Sciences sector, with a market capitalization of approximately $6.6B. The 52-week trading range was $38.31 to $86.74. This news item was assessed with positive market sentiment and an importance score of 7 out of 10. Source: Dow Jones Newswires.


Price Chart

Share this article

Copied!

IONS - Latest Insights

IONS
Nov 09, 2026, 7:00 AM EST
Filing Type: 8-K
Importance Score:
7
Price at Filing: $37.00
Real-time Price: $35.00 info
Change: -$2.00 (-5%) info
Market Cap: $6.551B info
IONS
Oct 23, 2026, 1:41 PM EDT
Filing Type: 8-K
Importance Score:
7
Price at Filing: $42.93
Real-time Price: $35.00 info
Change: -$7.93 (-18%) info
Market Cap: $6.551B info
IONS
Oct 20, 2026, 9:20 PM EDT
Source: BusinessWire
Importance Score:
8
Price at Filing: $45.20
Real-time Price: $35.00 info
Change: -$10.20 (-23%) info
Market Cap: $6.551B info
IONS
Oct 16, 2026, 6:45 AM EDT
Source: BusinessWire
Importance Score:
8
Price at Filing: $43.56
Real-time Price: $35.00 info
Change: -$8.56 (-20%) info
Market Cap: $6.551B info
IONS
Sep 23, 2026, 1:00 AM EDT
Source: BusinessWire
Importance Score:
9
Price at Filing: $45.75
Real-time Price: $35.00 info
Change: -$10.75 (-23%) info
Market Cap: $6.551B info